Cargando…

Relationship between plasma circulating cell-free DNA concentration and treatment outcomes including prognosis in patients with advanced non-small cell lung cancer

BACKGROUND: Some research found that elevated plasma cell-free DNA (cfDNA) concentrations and poor prognosis are associated in non-small cell lung cancer (NSCLC). However, more studies need to be carried out to verify this conclusion. Therefore, this study investigated the relationship between cfDNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Wei-Wei, Liu, Ying, Sha, Huan-Huan, Wen, Shao-Di, Fang, Ying, Zhou, Guo-Ren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503004/ https://www.ncbi.nlm.nih.gov/pubmed/37710221 http://dx.doi.org/10.1186/s12890-023-02586-2

Ejemplares similares

Plasma Concentrations and Cancer-Associated Mutations in Cell-Free Circulating DNA of Treatment-Naive Follicular Lymphoma for Improved Non-Invasive Diagnosis and Prognosis
por: Hatipoğlu, Tevfik, et al.
Publicado: (2022)

Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients
por: Mondelo-Macía, Patricia, et al.
Publicado: (2022)

Small Cell Size Circulating Aneuploid Cells as a Biomarker of Prognosis in Resectable Non-Small Cell Lung Cancer
por: Hong, Yang, et al.
Publicado: (2021)

The level and integrity of plasma circulating cell-free DNA in patients with primary multiple myeloma
por: Shen, Qian, et al.
Publicado: (2022)

Application of Circulating Tumor Cells and Circulating Free DNA from Peripheral Blood in the Prognosis of Advanced Gastric Cancer
por: Yu, Pengjie, et al.
Publicado: (2022)

Does Monitoring Total and Free Polymyxin B1 Plasma Concentrations Predict Polymyxin B-Induced Nephrotoxicity? A Retrospective Study in Critically Ill Patients
por: Deng, Yang, et al.
Publicado: (2022)

Prognosis of limited-stage small cell lung cancer with comprehensive treatment including radical resection
por: Zhong, Lili, et al.
Publicado: (2020)

Sex determination using circulating cell-free fetal DNA in small volume of maternal plasma in elephants
por: Vincze, Boglárka, et al.
Publicado: (2019)

The relationship between the preoperative plasma level of HIF-1α and clinic pathological features, prognosis in non-small cell lung cancer
por: He, Jiabei, et al.
Publicado: (2016)

Diagnostic Value of Concentration of Circulating Cell-Free DNA in Breast Cancer: A Meta-Analysis
por: Yu, Dandan, et al.
Publicado: (2019)

Evaluation of Plasma Circulating Cell Free DNA Concentration and Integrity in Patients with Prostate Cancer in Jamaica: A Preliminary Study
por: Condappa, Andrew, et al.
Publicado: (2020)

Plasma circulating cell-free mitochondrial DNA in depressive disorders
por: Fernström, Johan, et al.
Publicado: (2021)

An Advanced Model to Precisely Estimate the Cell-Free Fetal DNA Concentration in Maternal Plasma
por: Kang, Xiongbin, et al.
Publicado: (2016)

Imaging and histopathologic correlates of plasma cell-free DNA concentration and circulating tumor DNA in adult patients with newly diagnosed glioblastoma
por: Nabavizadeh, Seyed Ali, et al.
Publicado: (2020)

Relationship between Plasma Concentrations of Afatinib and the Onset of Diarrhea in Patients with Non-Small Cell Lung Cancer
por: Yokota, Hayato, et al.
Publicado: (2021)

Direct Quantification of Cell-Free, Circulating DNA from Unpurified Plasma
por: Breitbach, Sarah, et al.
Publicado: (2014)

Increased Plasma Circulating Cell-Free DNA Could Be a Potential Marker for Oral Cancer
por: Lin, Li-Han, et al.
Publicado: (2018)

Relationship Between the Free and Total Methotrexate Plasma Concentration in Children and Application to Predict the Toxicity of HD-MTX
por: Dong, Wei-Chong, et al.
Publicado: (2021)

Alteration of circulating natural autoantibodies to CD25-derived peptide antigens and FOXP3 in non-small cell lung cancer
por: Zhao, Huan, et al.
Publicado: (2018)

Detection of Methylated Septin 9 in Tissue and Plasma of Colorectal Patients with Neoplasia and the Relationship to the Amount of Circulating Cell-Free DNA
por: Tóth, Kinga, et al.
Publicado: (2014)

High preoperative plasma vasohibin‐1 concentration predicts better prognosis in patients with non–small cell lung carcinoma
por: Watanabe, Tatsuaki, et al.
Publicado: (2018)

Plasma circulating cell‐free MYCN gene: A noninvasive and prominent recurrence monitoring indicator of neuroblastoma
por: Liang, Ying, et al.
Publicado: (2022)

Association between anlotinib trough plasma concentration and treatment outcomes in advanced non-small-cell lung cancer
por: Chen, Ling, et al.
Publicado: (2023)

Meta-Analysis of Circulating Cell-Free DNA’s Role in the Prognosis of Pancreatic Cancer
por: Milin-Lazovic, Jelena, et al.
Publicado: (2021)

Circulating Cell-Free Nucleic Acids as Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer
por: Marin, Anelis Maria, et al.
Publicado: (2023)

T cell receptor repertoire profiling predicts the prognosis of HBV‐associated hepatocellular carcinoma
por: Lin, Kai‐Rong, et al.
Publicado: (2018)

Multiplex picoliter-droplet digital PCR for quantitative assessment of EGFR mutations in circulating cell-free DNA derived from advanced non-small cell lung cancer patients
por: Yu, Qian, et al.
Publicado: (2017)

A quantitative analysis of the potential biomarkers of non-small cell lung cancer by circulating cell-free DNA
por: Wei, Lirong, et al.
Publicado: (2018)

Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer
por: Wang, Huan-qiang, et al.
Publicado: (2018)

Monitoring early dynamic changes of plasma cell-free DNA and pretreatment pre-albumin to predict chemotherapy effectiveness and survival outcomes in advanced non-small cell lung cancer
por: Chen, Jia, et al.
Publicado: (2022)

Clinical Characteristics and Prognosis of Small Cell Carcinoma in the Nasopharynx: A Population-Based Study
por: Zhou, Yu-ling, et al.
Publicado: (2022)

Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma
por: Primerano, Simona, et al.
Publicado: (2016)

The influence of biological and lifestyle factors on circulating cell-free DNA in blood plasma
por: Yuwono, Nicole Laurencia, et al.
Publicado: (2021)

Circulating cell-free BRAF V600E during chemotherapy is associated with prognosis of children with Langerhans cell histiocytosis
por: Cui, Lei, et al.
Publicado: (2020)

Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer
por: Zhou, Xiaohan, et al.
Publicado: (2023)

Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells
por: Mack, Elisabeth K. M., et al.
Publicado: (2022)

Identification of plasma exosomes long non-coding RNA HAGLR and circulating tumor cells as potential prognosis biomarkers in non-small cell lung cancer
por: Rao, Le, et al.
Publicado: (2019)

Treatment monitoring of colorectal cancer by integrated analysis of plasma concentration and sequencing of circulating tumor DNA
por: Yeh, Yu-Min, et al.
Publicado: (2020)

Concentrations of Plasma Nucleosomes but Not Cell-Free DNA Are Prognostic in Dogs Following Trauma
por: Letendre, Jo-Annie, et al.
Publicado: (2018)

Effect of sample type on plasma concentrations of cell-free DNA and nucleosomes in dogs
por: Goggs, Robert
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uljg8v21kdvffndj6mdu0qbsej